Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NCT ID: NCT03154190

Last Updated: 2025-01-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-08

Study Completion Date

2022-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized pilot clinical trial studies health care coach support in reducing acute care use and cost in patients with cancer. Health care coach support may help cancer patients to make decisions about their care that matches what is important to them with symptom management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities.

SECONDARY OBJECTIVES:

I. To improve patients' experience of their care. II. Improve patient understanding of advanced care planning. III. To improve the receipt of goal concordant care. IV. To reduce total healthcare costs.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM A: Patients receive usual care.

ARM B: Patients undergo health care coach support with a baseline introduction (either telephonic or in-person) of the program followed by a visit (telephonic or in-person) with the health care coach after the first oncology appointment to discuss goals of care. The health care coach will contact patient based on patients' ongoing needs (weekly to monthly) and will conduct symptom assessments based on patients' treatment plans and symptoms.

After completion of study, patients are followed up for 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myeloid Leukemia Brain Glioblastoma Estrogen Receptor Negative Extensive Stage Small Cell Lung Carcinoma Head and Neck Carcinoma HER2/Neu Negative Hormone-Resistant Prostate Cancer Limited Stage Small Cell Lung Carcinoma Myelodysplastic Syndrome Progesterone Receptor Negative Progressive Disease Recurrent Carcinoma Stage II Pancreatic Cancer Stage II Rectal Cancer Stage IIA Pancreatic Cancer Stage IIA Rectal Cancer Stage IIB Pancreatic Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage III Colon Cancer Stage III Esophageal Cancer Stage III Gastric Cancer Stage III Non-Small Cell Lung Cancer Stage III Ovarian Cancer Stage III Pancreatic Cancer Stage III Rectal Cancer Stage III Skin Melanoma Stage IIIA Colon Cancer Stage IIIA Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIA Ovarian Cancer Stage IIIA Rectal Cancer Stage IIIA Skin Melanoma Stage IIIB Colon Cancer Stage IIIB Esophageal Cancer Stage IIIB Gastric Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IIIB Ovarian Cancer Stage IIIB Rectal Cancer Stage IIIB Skin Melanoma Stage IIIC Colon Cancer Stage IIIC Esophageal Cancer Stage IIIC Gastric Cancer Stage IIIC Ovarian Cancer Stage IIIC Rectal Cancer Stage IIIC Skin Melanoma Stage IV Bladder Cancer Stage IV Bone Sarcoma Stage IV Breast Cancer Stage IV Colon Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Stage IV Non-Small Cell Lung Cancer Stage IV Ovarian Cancer Stage IV Pancreatic Cancer Stage IV Rectal Cancer Stage IV Renal Cell Cancer Stage IV Skin Melanoma Stage IV Soft Tissue Sarcoma Stage IVA Bone Sarcoma Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Bone Sarcoma Stage IVB Colon Cancer Stage IVB Rectal Cancer Triple-Negative Breast Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A (usual care)

Patients receive usual care.

Group Type ACTIVE_COMPARATOR

Best Practice

Intervention Type OTHER

Receive usual care

Laboratory Biomarker Analysis

Intervention Type OTHER

Correlative studies

Survey Administration

Intervention Type OTHER

Ancillary studies

Arm B (health care coach support)

Patients undergo health care coach support with a baseline introduction (either telephonic or in-person) of the program followed by a visit (telephonic or in-person) with the health care coach after the first oncology appointment to discuss goals of care. The health care coach will contact patient based on patients' ongoing needs (weekly to monthly) and will conduct symptom assessments based on patients' treatment plans and symptoms.

Group Type EXPERIMENTAL

Laboratory Biomarker Analysis

Intervention Type OTHER

Correlative studies

Supportive Care

Intervention Type PROCEDURE

Undergo health care coach support

Survey Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Best Practice

Receive usual care

Intervention Type OTHER

Laboratory Biomarker Analysis

Correlative studies

Intervention Type OTHER

Supportive Care

Undergo health care coach support

Intervention Type PROCEDURE

Survey Administration

Ancillary studies

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

standard of care standard therapy Supportive Therapy Symptom Management Therapy, Supportive

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newly diagnosed patients for the following conditions

* Colon cancer stage III and IV
* Rectal cancer stage II, III, IV
* Glioblastoma multiforme (brain) -- no stage
* Non-small cell lung cancer stage IIIA, IIIB, IV
* Small cell lung cancer, limited stage and extensive stage
* Castration-resistant prostate cancer
* Head and neck cancer stage III and IV
* Gastric cancer stage III and IV
* Esophageal cancer stage III and IV
* Pancreatic cancer stage II, III, IV
* Renal cell carcinoma, stage IV
* Breast cancer, stage IV, if triple negative ER/PR/H2N negative or on systemic chemotherapy
* Sarcoma, stage IV
* Bladder carcinoma, stage IV
* Acute myeloid leukemia
* Melanoma, stage III and IV
* Ovarian cancer, stage III and IV
* High grade myelodysplastic syndrome (MDS)
* Any patient with recurrent or progressive cancer
* Patients must have the ability to understand and willingness to sign a written informed consent document
* Patient must have ongoing oncologic needs and plan to receive all care at the study institution and not already be in hospice or home-care

Exclusion Criteria

* Patients must have capacity to consent
* Pregnant patients are excluded
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Manali Indravadan Patel

Assistant Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manali Patel

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virginia K Crosson Cancer Center

Fullerton, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Patel MI, Kapphahn K, Dewland M, Aguilar V, Sanchez B, Sisay E, Murillo A, Smith K, Park DJ. Effect of a Community Health Worker Intervention on Acute Care Use, Advance Care Planning, and Patient-Reported Outcomes Among Adults With Advanced Stages of Cancer: A Randomized Clinical Trial. JAMA Oncol. 2022 Aug 1;8(8):1139-1148. doi: 10.1001/jamaoncol.2022.1997.

Reference Type DERIVED
PMID: 35771552 (View on PubMed)

Patel MI, Aguilar V, Sanchez B, Sisay E, Park DJ. Health care coach support to assist with advance care planning and symptom management -A randomized controlled trial. Contemp Clin Trials. 2021 Dec;111:106617. doi: 10.1016/j.cct.2021.106617. Epub 2021 Nov 5.

Reference Type DERIVED
PMID: 34749008 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VAR0134

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.